Case File №
#VI-2026-0850
Xingtai Pukelai Technology Co
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
34 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 6 | 6.9 | 4.1 | 9.9 | 11 Aug 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 |
| 4-Piperidone CAS 41661-47-6 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| ACE-031 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 3 Jul 2025 |
| Alprostadil | X N/A | 1 | 7.4 | 7.4 | 7.4 | 27 Feb 2025 |
| Anadrol (Oxymetholone) | X N/A | 1 | 9.0 | 9.0 | 9.0 | 9 Jun 2025 |
| APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 2 Jul 2025 |
| BAM15 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 1 | 9.4 | 9.4 | 9.4 | 17 Dec 2024 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.2 | 4.2 | 4.2 | 13 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 8.1 | 8.1 | 8.1 | 13 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 9.0 | 9.0 | 9.0 | 16 Mar 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 9.5 | 9.5 | 9.5 | 8 Jul 2025 |
| Dianabol | X N/A | 1 | 6.1 | 6.1 | 6.1 | 8 Jul 2025 |
| Dihexa | X N/A | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 |
| DNP | X N/A | 1 | 8.4 | 8.4 | 8.4 | 27 Feb 2025 |
| DSIP | X N/A | 1 | 7.9 | 7.9 | 7.9 | 25 Apr 2025 |
| EPO | X N/A | 1 | 4.0 | 3.3 | 3.3 | 27 Feb 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 7.2 | 7.2 | 7.2 | 16 Mar 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 7 May 2025 |
| HCG | X N/A | 1 | 9.4 | 9.4 | 9.4 | 11 Jun 2025 |
| HGH Fragment 176-191 | X N/A | 1 | 5.7 | 5.7 | 5.7 | 17 Dec 2024 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 5.8 | 5.8 | 5.8 | 28 Mar 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 4.6 | 4.6 | 4.6 | 14 Jan 2025 |
| LL37 | X N/A | 1 | 6.0 | 6.0 | 6.0 | 21 May 2025 |
| NPP | X N/A | 1 | 7.6 | 7.6 | 7.6 | 17 Dec 2024 |
| Pinealon | X N/A | 1 | 4.0 | 2.2 | 2.2 | 3 Jun 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 7.5 | 7.5 | 7.5 | 21 May 2025 |
| SS-31 | X N/A | 1 | 7.0 | 7.0 | 7.0 | 27 Feb 2025 |
| Tesofensine | X N/A | 1 | 7.0 | 7.0 | 7.0 | 21 May 2025 |
| Testosterone Cypionate Raw | X N/A | 1 | 7.8 | 7.8 | 7.8 | 9 Jun 2025 |
| Testosterone Phenylpropionate Raw | X N/A | 1 | 8.6 | 8.6 | 8.6 | 3 Jul 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 25 Apr 2025 |
Exhibit II
Evidence Log
39 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Dianabol | 6.2 A | 100mg | 114.5mg | +14.5% | 96.98% | m4dr8i | Lab F | Public |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 5.7 B | 10mg | 12.4mg | +24.4% | 98.15% | ugxrw6 | Lab B | Public |
| 24 May 2026 | Thymosin Alpha-1 | 8.5 A | 15mg | 15.4mg | +2.8% | 95.64% | 6xp9ou | Lab C | Community |
| 24 May 2026 | DNP | 6.0 A | 25mg | 21.3mg | -14.7% | 95.52% | pc3xts | Lab D | Community |
| 24 May 2026 | Anadrol (Oxymetholone) | 9.9 A | 20mg | 24.8mg | +24.2% | 96.41% | 9776fc | Lab G | Public |
| 24 May 2026 | HCG | 9.7 A | 30mg | 34.0mg | +13.3% | 95.23% | viyzxx | Lab G | Public |
| 24 May 2026 | BAM15 | 6.8 A | 20mg | 21.0mg | +5.0% | 99.72% | hd92s5 | Lab D | Public |
| 23 May 2026 | Dihexa | 5.5 B | 100mg | 90.3mg | -9.7% | 98.15% | x0xv5f | Lab E | Public |
| 21 May 2026 | APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 | 5.0 B | 1g | 0.9g | -5.2% | 95.34% | x780uw | Lab D | Community |
| 21 May 2026 | Pinealon | 4.4 C | 30mg | 33.1mg | +10.3% | 95.06% | cn9zfu | Lab E | Community |
| 21 May 2026 | Testosterone Phenylpropionate Raw | 9.4 A | 5g | 4.6g | -8.3% | 95.07% | 3spbm5 | Lab B | Public |
| 21 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.0 B | 15mg | 14.1mg | -6.2% | 97.40% | hf8mch | Lab A | Public |
| 21 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.6 A | 20mg | 22.8mg | +13.9% | 96.38% | z9hwg9 | Lab A | Public |
| 21 May 2026 | HGH Fragment 176-191 | 5.7 B | 30mg | 33.2mg | +10.5% | 95.88% | gwxw13 | Lab E | Public |
| 19 May 2026 | Alprostadil | 8.5 A | 2mg | 2.0mg | +0.5% | 95.82% | zzafxw | Lab E | Community |
| 17 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.3 B | 10mg | 10.5mg | +4.9% | 96.02% | 9yq0hk | Lab D | Public |
| 17 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.4 A | 20mg | 20.8mg | +3.8% | 98.10% | xuol6f | Lab B | Community |
| 26 Jan 2026 | 4-Piperidone CAS 41661-47-6 | 6.5 A | 100g | 111.5g | +11.5% | 97.13% | 0xt377 | Lab C | Public |
| 26 Jan 2026 | ACE-031 | 7.3 A | 50mg | 55.5mg | +11.1% | 98.91% | 9kki56 | Lab B | Public |
| 9 Jan 2026 | DSIP | 7.9 A | 15mg | 17.7mg | +18.0% | 96.71% | 8nbhgc | Lab F | Public |
| 9 Jan 2026 | SS-31 | 8.1 A | 20mg | 23.0mg | +14.8% | 97.08% | 7uqr5z | Lab D | Community |
| 7 Jan 2026 | NPP | 5.9 B | 250mg/ml | 238.2mg/ml | -4.7% | 96.32% | kh700e | Lab A | Public |
| 6 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 9.8 A | 300mg/ml | 309.4mg/ml | +3.1% | 98.64% | 1vpcjm | Lab E | Community |
| 6 Jan 2026 | LL37 | 5.9 B | 20mg | 18.9mg | -5.3% | 95.48% | xcybna | Lab C | Public |
| 29 Dec 2025 | Retatrutide | 4.3 D | 30mg | 32.9mg | +9.7% | 98.67% | (no batch ID) | Lab E | Public |
| 13 Dec 2025 | Retatrutide | 4.1 D | 30mg | 25.3mg | -15.7% | 99.30% | (no batch ID) | Lab G | Public |
| 13 Dec 2025 | Retatrutide | 7.5 A | 60mg | 62.7mg | +4.5% | 99.70% | (no batch ID) | Lab G | Public |
| 12 Dec 2025 | 4-Anilinopiperidine CAS 99918-43-1 | 6.0 A | 100g | 106.8g | +6.8% | 98.80% | k1061s | Lab A | Community |
| 6 Dec 2025 | Retatrutide | 7.7 A | 20mg | 20mg | 99.77% | (no batch ID) | Lab E | Public | |
| 5 Dec 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.5 B | 5mg | 4.8mg | -3.9% | 97.09% | ks7klu | Lab A | Community |
| 5 Dec 2025 | Tesofensine | 6.4 A | 25mg | 25.4mg | +1.6% | 96.73% | t76l8u | Lab E | Public |
| 23 Nov 2025 | LGD-4033 (Ligandrol) | 4.0 C | 50mg | 56.7mg | +13.4% | 95.04% | gz1nju | Lab B | Public |
| 17 Nov 2025 | CJC-1295 With DAC | 10.0 A | 2mg | 1.9mg | -5.9% | 96.63% | j40sgh | Lab D | Public |
| 14 Nov 2025 | EPO | 4.0 C | 2mg | 2.1mg | +5.6% | 95.79% | 773m09 | Lab G | Public |
| 14 Nov 2025 | Testosterone Cypionate Raw | 7.4 A | 10g | 12.0g | +20.5% | 97.91% | fhsayy | Lab A | Public |
| 5 Nov 2025 | Halotestin (Fluoxymesterone) | 6.0 A | 100mg | 117.6mg | +17.6% | 97.10% | dt8881 | Lab A | Public |
| 3 Oct 2025 | Cerebrolysin | 6.6 A | 20mg | 24.3mg | +21.3% | 98.81% | 3kcxgg | Lab F | Community |
| 4 Sep 2025 | Retatrutide | 9.9 A | 20mg | 20.8mg | +4.0% | 99.87% | Aug 1st 2025 | Lab E | Public |
| 11 Aug 2025 | Retatrutide | 8.0 A | 30mg | 29mg | -3.3% | 99.95% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —